Decitabine treatment of latency I BL results in hypomethylation at the LMP1 and Cp promoters and induces expression EBNA2 and LMP1 in-vitro and in-vivo in xenograft models of latency I EBV+ BL. The gene discussed is PDLIM7; the disease is Burkitt lymphoma.